Global Prostate Cancer Drugs Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. Prostate Cancer is the most common type of cancer in men globally. It is the cancer of prostate gland which is a walnut-sized gland present in men. The function of this gland is to produce seminal fluid that nurtures and transports sperm.
The factors that propel the growth of the Prostate Cancer Drugs Market include increasing demand, rapid urbanization & industrialization, rise in research activities and product development & technological innovations. In addition, the key factors that fuel the market growth includes geriatric population, growing incidences of prostate cancer, awareness among people and increasing number of diagnostic centers.
On the other hand, there are also factors that may hamper the growth of the market such as high cost. Prostate Cancer Drugs Market is classified on the basis of product type, applications, distribution channel and geography. The market is segmented by product type as chemotherapy, hormonal therapy, immunotherapy, targeted therapy and others. The chemotherapy segment comprises systemic chemotherapy, regional chemotherapy and others.
The hormonal therapy segment comprises luteinizing hormone-releasing hormone analogs, luteinizing hormone-releasing, hormone antagonists and antiandrogens. The targeted therapy segment comprises apoptosis inducing drugs, angiogenesis inhibitor, signal transduction inhibitor and others. Prostate Cancer Drugs Market is classified on applications as clinics, hospital and others. Prostate Cancer Drugs Industry is segmented by distribution channel as online stores, hospital pharmacy, retail pharmacy and others. Prostate Cancer Drugs Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and African region consists of GCC, South Africa and North Africa.
By geography, North America is projected to hold a major share of the Prostate Cancer Drugs Market. The key factors that fuel the growth of this region include increasing demand, growing incidence of prostate cancer, well established healthcare infrastructure & facilities and rising R&D undertakings. In contrast, Asia Pacific is expected to show rapid growth rates in the market. The factors that aid to the growth of this region include growing awareness, large population base and increasing incidence of prostate cancer.
Some of the key players that fuel the growth of the Prostate Cancer Drugs Market include AbbVie, Astra Zeneca, Amgen, Astellas Pharma, Bayer HealthCare, BMS, Boehringer Ingelheim, Endo Pharmaceuticals, Foresee Pharmaceuticals, Ferring Pharmaceutical, GlaxoSmithKline, Janssen Pharmaceuticals, Johnson & Johnson, Merck Group, Novartis, Northwest Biotherapeutics, Spectrum Pharmaceuticals, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceutical, Tokai Pharmaceuticals, and others. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Prostate Cancer Drugs in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Prostate Cancer Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Astellas Pharma
• Astra Zeneca
• Johnson & Johnson
• Merck Group
• Bayer HealthCare
• Ferring Pharmaceutical
• Janssen Pharmaceuticals
• Endo Pharmaceuticals
• Takeda Pharmaceuticals
• Northwest Biotherapeutics
• Teva Pharmaceutical
• Boehringer Ingelheim
• Foresee Pharmaceuticals
• Tokai Pharmaceuticals
• Spectrum Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Hormonal Therapy
• Targeted Therapy
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Research Support Specialist, USA